Finally, LIPH‐positive breast cancer in patients with TNBC was associated with a significantly shorter disease‐free survival (DFS) compared to LIPH‐negative breast cancer (P = 0.0273, Figure 1D). The gene discussed is LIPH; the disease is breast carcinoma.